Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study
Clinical trial NCT04978584 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04978584
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-03
- Primary completion
- 2027-01-16
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.